Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Haemonetics Corp shares valued at $98,784 were purchased by KROLL MARK W on Nov 10 ’25. At $70.56 per share, KROLL MARK W acquired 1,400 shares. The insider’s holdings grew to 24,757 shares worth approximately $1.98 million following the completion of this transaction.
Also, Llorens Josep purchased 18,630 shares, netting a total of over 1,396,132 in proceeds.
Before that, Strong Stewart W had added 708 shares to its account. In a trade valued at $50,593, the Former Officer bought Haemonetics Corp shares for $71.46 each.
As published in a research note from Needham on December 15, 2025, Haemonetics Corp [HAE] has been rated down from a Buy to a Hold. Analysts at Citigroup downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid December. As of August 11, 2025, Raymond James has decreased its “Strong buy” rating to a “an Outperform” for HAE. Earlier on August 08, 2025, Barrington Research resumed its rating. Their recommendation was “an Outperform” for HAE stock.
Analyzing HAE Stock Performance
On last trading session, Haemonetics Corp [NYSE: HAE] plunged -0.44% to $80.01. The stock’s lowest price that day was $79.61, but it reached a high of $80.22 in the same session. During the last five days, there has been a surge of approximately 0.04%. Over the course of the year, Haemonetics Corp shares have jumped approximately 6.06%. Shares of the company reached a 52-week high of $87.32 on 12/10/25 and a 52-week low of $47.31 on 09/26/25.
Support And Resistance Levels for Haemonetics Corp (HAE)
According to the 24-hour chart, there is a support level at 79.61, which, if violated, would cause prices to drop to 79.20. In the upper region, resistance lies at 80.32. The next price resistance is at 80.62. RSI (Relative Strength Index) is 57.48 on the 14-day chart, showing neutral technical sentiment.
Is Haemonetics Corp subject to short interest?
Stocks of Haemonetics Corp saw a sharp rise in short interest on 2025-11-28 jumping by 0.5 million shares to 3.62 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 3.12 million shares. A jump of 13.76% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.31 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.31.
Which companies own the most shares of Haemonetics Corp (HAE)?
In terms of Haemonetics Corp share price expectations, FactSet research, analysts set an average price target of 90 in the next 12 months, up nearly 12.0% from the previous closing price of $80.36. Analysts anticipate Haemonetics Corp stock to reach 99 by 2025, with the lowest price target being 68. In spite of this, 4 analysts ranked Haemonetics Corp stock as Buy at the end of 2025. On August 08, 2025, JP Morgan assigned a price target of “a Neutral” to the stock and downgraded coverage with a $62.
